Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
8.72
-0.58 (-6.24%)
At close: Apr 1, 2025, 4:00 PM
8.43
-0.29 (-3.36%)
After-hours: Apr 1, 2025, 6:06 PM EDT

Tyra Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-86.48-69.13-55.33-26.29-9.34
Upgrade
Depreciation & Amortization
0.520.360.30.140.05
Upgrade
Loss (Gain) From Sale of Assets
--000
Upgrade
Loss (Gain) From Sale of Investments
-5.88-1.25---
Upgrade
Stock-Based Compensation
22.813.5310.592.890.44
Upgrade
Other Operating Activities
----0.02
Upgrade
Change in Accounts Payable
-0.749.372.361.491.02
Upgrade
Change in Other Net Operating Assets
0.02-3.01-8.2-1.970.05
Upgrade
Operating Cash Flow
-69.77-50.14-50.29-23.75-7.76
Upgrade
Capital Expenditures
-0.66-0.77-0.56-0.66-0.31
Upgrade
Sale of Property, Plant & Equipment
---0.02-
Upgrade
Investment in Securities
-97.74-143.84---
Upgrade
Investing Cash Flow
-98.4-144.61-0.56-0.65-0.31
Upgrade
Long-Term Debt Repaid
----0.01-0.02
Upgrade
Net Debt Issued (Repaid)
----0.01-0.02
Upgrade
Issuance of Common Stock
202.561.540.63181.730.14
Upgrade
Other Financing Activities
-0.42----
Upgrade
Financing Cash Flow
202.141.540.63311.3523.43
Upgrade
Net Cash Flow
33.96-193.21-50.21286.9615.36
Upgrade
Free Cash Flow
-70.44-50.91-50.84-24.41-8.08
Upgrade
Free Cash Flow Per Share
-1.23-1.19-1.21-1.77-5.24
Upgrade
Cash Interest Paid
---1.240
Upgrade
Levered Free Cash Flow
-41.15-29.49-28.56-14.18-8.98
Upgrade
Unlevered Free Cash Flow
-41.15-29.49-28.56-14.18-8.97
Upgrade
Change in Net Working Capital
-1.31-7.372.050.123.34
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q